Systems vaccinology of adjuvanted vaccines reveals early innate signatures predictive of adaptive immunity

Nature

Adjuvants shape the quality and durability of vaccine responses through early innate immune programs. Using multi-omics profiling of human vaccinees, we identify conserved early transcriptional and cellular signatures that predict subsequent adaptive responses across distinct adjuvant platforms, providing a framework for rational adjuvant selection.

Related products

Catalog No.	Product Name	Description	Target
HF998207	Anti-Human CD4 Antibody (5A8)	Anti-Human CD4 Recombinant Antibody (5A8) (HF998207) is a mouse monoclonal antibody detecting CD4 in FCM. Suitable for Human. Highlights ●Affinity Purified — Minimal background and high purity for reliable results.	CD4, T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4

Recombinant Proteins

Antibodies

Assay Kits

Systems vaccinology of adjuvanted vaccines reveals early innate signatures predictive of adaptive immunity